
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted therapy for the treatment of alcohol use disorder.

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted therapy for the treatment of alcohol use disorder.